Compare SONO & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SONO | PRGO |
|---|---|---|
| Founded | 2002 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2018 | 2013 |
| Metric | SONO | PRGO |
|---|---|---|
| Price | $15.80 | $14.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $19.67 | ★ $20.33 |
| AVG Volume (30 Days) | ★ 2.3M | 2.0M |
| Earning Date | 05-04-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 8.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $1,443,276,000.00 | $800,000.00 |
| Revenue This Year | $5.04 | N/A |
| Revenue Next Year | $6.53 | N/A |
| P/E Ratio | $20.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.63 | $12.17 |
| 52 Week High | $19.82 | $30.93 |
| Indicator | SONO | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 44.20 |
| Support Level | $14.44 | $13.58 |
| Resistance Level | $15.95 | $14.82 |
| Average True Range (ATR) | 0.83 | 0.50 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 40.94 | 63.78 |
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.